Antiangiogene Therapie am vorderen Augenabschnitt
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/content/pdf/10.1007/s00347-007-1512-2.pdf
Reference36 articles.
1. Bock F, Onderka J, Dietrich T et al. (2007) Bevacizumab is a potent inhibitor of inflammatory angiogenesis and lymphangiogenesis in the cornea. Invest Ophthalmol Vis Sci (im Druck)
2. Chen L, Hamrah P, Cursiefen C et al. (2004) Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) mediates dendritic cell migration to lymph nodes and induction of immunity to corneal transplants. Nature Medicine 10: 813–815
3. Cursiefen C (2007) Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 92: 50–57
4. Cursiefen C, Schlötzer-Schrehardt U, Küchle M et al. (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and Podoplanin. Invest Ophthalmol Vis Sci 43: 2127–2135
5. Cursiefen C, Chen L, Dana MR et al. (2003) Corneal lymphangiogenesis: Evidence, mechanisms and implications for transplant immunology. Cornea 22: 273–2781
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The novel role of lymphatic vessels in the pathogenesis of ocular diseases;Progress in Retinal and Eye Research;2023-09
2. Sustained Inhibition of VEGF and TNF-α Achieves Multi-Ocular Protection and Prevents Formation of Blood Vessels after Severe Ocular Trauma;Pharmaceutics;2023-07-31
3. A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma;2023-03-15
4. VEGF-targeted scFv inhibits corneal neovascularization via STAT3 pathway in alkali burn model;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2023-02
5. Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye;Translational Vision Science & Technology;2020-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3